Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Digital Inventory Platform Improves Data Access

March 03, 2021

A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Necessity Drives Just-in-Time Approaches to Clinical Trials Supply

March 02, 2021

The COVID-19 pandemic is pushing more companies to adopt just-in-time practices, but success demands careful upfront risk assessment and planning.

Meeting CGT Demand

March 02, 2021

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

March 01, 2021

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Avid Bioservices Expands Biologics Manufacturing Capacity

February 22, 2021

The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.

Wavelength Pharmaceuticals Acquires Vanamali Organics

February 18, 2021

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Cascade Chemistry Expands API Manufacturing Capacity

February 18, 2021

Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

Quotient Sciences Acquires CDMO Arcinova

February 17, 2021

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.